https://openalex.org/T12689
This cluster of papers focuses on the use of silymarin, a flavonolignan complex derived from milk thistle, in the treatment of liver diseases, including hepatitis and hepatocellular carcinoma. It explores silymarin's hepatoprotective and antioxidant effects, its potential as a supportive treatment in liver diseases, its role in cancer treatment and chemoprevention, as well as its pharmacokinetics and toxicity.
@prefix oasubfields: <https://openalex.org/subfields/> .
@prefix openalex: <https://lambdamusic.github.io/openalex-hacks/ontology/> .
@prefix owl: <http://www.w3.org/2002/07/owl#> .
@prefix rdfs: <http://www.w3.org/2000/01/rdf-schema#> .
@prefix skos: <http://www.w3.org/2004/02/skos/core#> .
@prefix xsd: <http://www.w3.org/2001/XMLSchema#> .
<https://openalex.org/T12689> a skos:Concept ;
rdfs:label "Silymarin in Liver Diseases and Cancer Treatment"@en ;
rdfs:isDefinedBy openalex: ;
owl:sameAs <https://en.wikipedia.org/wiki/Silymarin>,
<https://openalex.org/T12689> ;
skos:broader oasubfields:2740 ;
skos:definition "This cluster of papers focuses on the use of silymarin, a flavonolignan complex derived from milk thistle, in the treatment of liver diseases, including hepatitis and hepatocellular carcinoma. It explores silymarin's hepatoprotective and antioxidant effects, its potential as a supportive treatment in liver diseases, its role in cancer treatment and chemoprevention, as well as its pharmacokinetics and toxicity."@en ;
skos:inScheme openalex: ;
skos:prefLabel "Silymarin in Liver Diseases and Cancer Treatment"@en ;
openalex:cited_by_count 143214 ;
openalex:works_count 10071 .